Using a Treat-to-Target Approach to Manage Patients With Inflammatory Bowel Disease

G&H What led to the concept of a treat-to-target approach for the management of patients with inflammatory bowel disease? CS Traditional management approaches to inflammatory bowel […]

Current Approach to Postoperative Crohn’s Disease

G&H How common are endoscopic recurrence and clinical recurrence of Crohn’s disease following surgery? MR The simple answer is that both are common. Endoscopic recurrence refers […]

Racial and Ethnic Disparities in Inflammatory Bowel Disease

G&H What are the prevalence and incidence rates of inflammatory bowel disease by race and ethnicity, and how have they changed? MB The prevalence and incidence […]

When to Perform Fecal Diversion in Patients With Crohn’s Disease

G&H What is the best choice for fecal diversion—an ileostomy or a colostomy—and how do these procedures compare? JA Typically, I favor an ileostomy over a […]

Transmural Healing in Inflammatory Bowel Disease

G&H How can transmural healing be defined? DR Transmural healing refers to evidence of healing of all layers of the bowel, with the recognition that inflammation […]

Combining Mechanisms of Action to Treat Patients With Inflammatory Bowel Disease

G&H What is the rationale for combining mechanisms of action to treat patients with inflammatory bowel disease? SD A therapeutic ceiling has been achieved in that […]

Using a Clinical Decision Support Tool for Inflammatory Bowel Disease

G&H Why was there a need to develop a clinical decision support tool for inflammatory bowel disease? PD All of the US Food and Drug Administration […]

Artificial Intelligence in Inflammatory Bowel Disease

G&H How can artificial intelligence be defined, and why is it being used in inflammatory bowel disease? RS The colloquial concept of artificial intelligence (AI) represents […]

Vaccination Updates for Patients With Inflammatory Bowel Disease

G&H Why are vaccinations important for patients with inflammatory bowel disease? FF As many as 70% of patients with inflammatory bowel disease (IBD) will be on […]

Histologic Healing in Inflammatory Bowel Disease

G&H How can histologic healing be best defined in patients with inflammatory bowel disease? BC This is a complex question to answer. Despite increasing evidence suggesting […]

Gastroduodenal and Jejunoileal Crohn’s Disease

G&H How common are gastroduodenal and jejunoileal Crohn’s disease among the various types of Crohn’s disease? BC Crohn’s disease can occur anywhere from the mouth to […]

Approach to Treatment Failure in Inflammatory Bowel Disease

G&H What are the current options for conventional therapy for inflammatory bowel disease, and what are the typical response rates? AM Multiple options have been approved […]

Reviewing the Use of Vedolizumab for the Treatment of Patients With Crohn’s Disease

G&H What is the current indication for vedolizumab in patients with Crohn’s disease? SH Vedolizumab (Entyvio, Takeda) is currently indicated for the treatment of moderate to […]

De-escalation of Therapy for Patients With Inflammatory Bowel Disease

G&H What are the most common reasons for de-escalating therapy for inflammatory bowel disease? RU There are a number of reasons that doctors discuss therapy de-escalation […]

The Transition From Pediatric to Adult Inflammatory Bowel Disease Care

Gastroenterology & Hepatology Volume 12, Issue 6, June 2016 Stacy A. Kahn, MD Assistant Professor of Pediatrics and Medicine Section of Pediatric Gastroenterology, Hepatology, & Nutrition […]

Clostridium difficile Infection and Inflammatory Bowel Disease

Gastroenterology & Hepatology Volume 12, Issue 5, May 2016 David Binion, MD Professor of Medicine Professor of Clinical and Translational Science University of Pittsburgh School of […]

Using Institutional Databases to Study Inflammatory Bowel Disease

Gastroenterology & Hepatology April 2016, Volume 12, Issue 4 David Binion, MD Professor of Medicine Co-Director, IBD Center–Translational Research University of Pittsburgh Pittsburgh, Pennsylvania G&H What […]

Emerging Trends of Inflammatory Bowel Disease in Asia

Gastroenterology & Hepatology March 2016, Volume 12, Issue 3 Siew C. Ng, MBBS, PhD Associate Professor Department of Medicine and Therapeutics Institute of Digestive Disease State […]

European Experience of Infliximab Biosimilars for the Treatment of Inflammatory Bowel Disease

Gastroenterology & Hepatology February 2016, Volume 12, Issue 2 Peter Lakatos, MD Associate Professor Head of Gastroenterology/Hepatology Unit and Endoscopy Semmelweis University Budapest, Hungary G&H What […]

The Role of Diet in Inflammatory Bowel Disease

Gastroenterology & Hepatology January 2016, Volume 12, Issue 1 James D. Lewis, MD, MSCE Professor of Medicine Division of Gastroenterology, Department of Medicine Center for Clinical […]